- KR₩60bn
- KR₩52bn
- KR₩60bn
Annual balance sheet for C&R Research, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 14,759 | 19,450 | 10,691 | 11,902 | 13,121 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 23.9 | 16,202 | 18,428 | 24,390 | 30,640 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 14,783 | 35,771 | 29,319 | 36,522 | 44,330 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | 31,463 | 29,938 | 29,864 | 30,635 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 14,783 | 71,272 | 70,507 | 77,848 | 85,602 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | — | 36,681 | 30,815 | 31,555 | 35,373 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,851 | 40,788 | 34,451 | 35,616 | 38,697 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 12,932 | 30,484 | 36,056 | 42,231 | 46,905 |
Total Liabilities & Shareholders' Equity | 14,783 | 71,272 | 70,507 | 77,848 | 85,602 |
Total Common Shares Outstanding |